Key factors for overcoming psychological insulin resistance: an examination of patient perspectives through content analysis. Issue 1 (11th December 2019)

• Record Type: Journal Article
• Authors: Stuckey, Heather; Fisher, Lawrence; Polonsky, William H; Hessler, Danielle; Snoek, Frank J; Tang, Tricia S; Hermanns, Norbert; Mundet-Tuduri, Xavier; da Silva, Maria Elizabeth Rossi; Sturt, Jackie; Okazaki, Kentaro; Cao, Dachuang; Hadjiyianni, Irene; Ivanova, Jasmina I; Desai, Urvi; Perez-Nieves, Magaly
• Is Part Of: BMJ open diabetes research and care. Volume 7:Issue 1(2019)
• Publication Date: 2019-12-11
• Subjects: type 2 diabetes -- psychological insulin resistance -- patient-provider relationship; Diabetes -- Periodicals; 616.462005
• DOI: 10.1136/bmjdrc-2019-000723
• Languages: English
• ISSNs: 2052-4897

Abstract

Abstract : Objective: To understand participant perceptions about insulin and identify key behaviors of healthcare professionals (HCPs) that motivated initially reluctant adults from seven countries (n=40) who had type 2 diabetes (T2D) to start insulin treatment. Research design and methods: Telephone interviews were conducted with a subset of participants from an international investigation of adults with T2D who were reluctant to start insulin (EMOTION). Questions related to: (a) participants' thoughts about insulin before and after initiation; (b) reasons behind responses on the survey that were either 'not helpful at all' or 'helped a lot'; (c) actions their HCP may have taken to help start insulin treatment; and (d) advice they would give to others in a similar situation of starting insulin. Responses were coded by two independent reviewers (kappa 0.992). Results: Starting insulin treatment was perceived as a negative experience that would be painful and would lead down a 'slippery slope' to complications. HCPs engaged in four primary behaviors that helped with insulin acceptance: (1) showed the insulin pen/needle and demonstrated the injection process; (2) explained how insulin could help with diabetes control and reduce risk of complications; (3) used collaborative communication style; and (4) offered support and willingness to answer questions so that participants would not be 'on their own'. Following initiation, most participants noted that insulin was not 'as bad as they thought' and recommended insulin to other adults with T2D. Conclusions: Based on these themes, two actionable strategies are suggested for HCPs to help people with psychological insulin resistance: (1) demonstrate the injection process and discuss negative perceptions of insulin as well as potential benefits; (2) offer autonomy in a person-centred collaborative approach, but provide support and accessibility to address concerns. These findings help HCPs to better understand ways in which they can engage reluctant people with T2D with specific strategies.